BackRaphael Pharmaceutical Overview

Raphael Pharmaceutical Net Tangible Assets

Latest net tangible assets for RAPH: $-1.9M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$-1.89M
↑ 79.87% YoYΔ $-837000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Raphael Pharmaceutical Net Tangible Assets History

Loading

Raphael Pharmaceutical vs. peers: Net Tangible Assets Comparison

Loading

Raphael Pharmaceutical Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Raphael Pharmaceutical (RAPH) FAQ

Raphael Pharmaceutical posts a net tangible assets of $-1.9M as of June 2026. That compares with $-1M in the prior-year period — down 79.9% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Raphael Pharmaceutical's net tangible assets was $-1M. The latest reading is $-1.9M — a 79.9% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Net Tangible Assets is one piece of Raphael Pharmaceutical's financial statement story. At $-1.9M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for RAPH's net tangible assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Raphael Pharmaceutical's other metric pages and overview cover the third.